Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

221.32 -1.19 (-0.53%)
Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
News headline image
Value Investing Is Not Dead - It Just Got Smarter ↗
 
Via Benzinga
News headline image
FDA Panel Reiterates the Cancer Risks of Talc
From Beasley Allen Law Firm
Via Business Wire
News headline image
This Healthy High-Yielding Dividend Stock Just Increased Its Payment for the 48th Year in a Row ↗
Via The Motley Fool
Topics World Trade
News headline image
3 Buy-and-Hold Stocks Long-Term Investors Can Love in Any Market
For buy-and-hold investors looking for some quality names to navigate a turbulent market, here are three stocks to consider 
Via MarketBeat
Topics ETFs Economy
News headline image
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
From Johnson & Johnson
Via Business Wire
News headline image
Apple, Nvidia, GM: CEOs Are Talking About Being American-Made Again ↗
US companies are reshoring manufacturing operations & investing billions in the country, led by Apple & Nvidia for tech, J&J & Eli Lilly for healthcare, Anheuser-Busch for beer, & Cra-Z-Art for toys.... 
Via Benzinga
News headline image
Market Whales and Their Recent Bets on JNJ Options ↗
 
Via Benzinga
News headline image
Meet the Warren Buffett Investment That's Gained 5,502,284% and Looks Set to Soar Even Higher ↗
Warren Buffett has had a lot of successful investments, but one in particular has crushed the stock market time and again. 
Via The Motley Fool
News headline image
3 Magnificent Stocks That Are Passive Income Machines ↗
Via The Motley Fool
News headline image
US-China Trade Truce, Trump's Middle East Deals Spark Wall Street Rally: This Week In Markets ↗
U.S. and China cut tariffs by 115 points, sparking a stock rally and improving trade outlook. Trump secures $2 trillion in Gulf deals. 
Via Benzinga
Topics Government World Trade
News headline image
Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails
From Nachawati Law Group
Via Business Wire
News headline image
Why Pfizer Is Poised For A Strong Comeback: My Top Pick For 2025 ↗
For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying opportunity. 
Via Benzinga
News headline image
Jim Cramer Says Even 'Safety' Stocks Look Risky, Warns Of 'Wild Card' In Washington And Rising Treasury Yields As Reasons To Stay Away From Sure Bets ↗
Rising bond yields and uncertain politics make 'safety' stocks less appealing, says Jim Cramer. Even Procter & Gamble and Johnson & Johnson suddenly feel shaky to the market guru. 
Via Benzinga
Topics Bonds
News headline image
Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030 ↗
Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states. 
Via Benzinga
News headline image
CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up ↗
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26. 
Via Benzinga
News headline image
The Smartest Dividend Stocks to Buy With $5,000 Right Now ↗
Via The Motley Fool
Topics Economy Retirement
News headline image
Trump Unveils 'Historic And Transformative' $600 Billion Saudi Deal, Predicts Markets Will 'Go A Lot Higher' ↗
President Trump unveils a $600 billion Saudi investment package into the U.S., with major deals in tech, defense, energy, and healthcare. 
Via Benzinga
Topics Government
News headline image
13 Analysts Have This To Say About Johnson & Johnson ↗
 
Via Benzinga
News headline image
Peering Into Johnson & Johnson's Recent Short Interest ↗
 
Via Benzinga
News headline image
Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News ↗
It's biggest product will be up for price negotiations under the Inflation Reduction Act much sooner than expected. 
Via Investor's Business Daily
Topics Economy Government
News headline image
Top S&P500 movers in Monday's pre-market session ↗
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
News headline image
S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform ↗
It's still unclear how President Donald Trump plans to tie drug prices in the U.S. to international prices. 
Via Investor's Business Daily
Topics Government Stocks
News headline image
Mark Cuban Slams Charlie Kirk Over Drug Price Debate, Says PBMs — Not Big Pharma — Are The Real Villains: 'For Your Company...Ask Your PBM For A List Of Claims' ↗
Mark Cuban, the billionaire entrepreneur, challenged Trump-supporter and political activist Charlie Kirk's stance on high drug prices, asserting that Pharmacy Benefit Managers (PBMs) are the main... 
Via Benzinga
News headline image
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots ↗
Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket ↗
What Happened: On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the "most consequential executive order" in U.S. history, aimed at lowering prescription... 
Via Benzinga
Topics Government
News headline image
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency' ↗
Trump vows to slash drug prices with new executive order, potentially dropping them by 30-80%. 
Via Benzinga
Topics Government
News headline image
Protagonist/Johnson & Johnson Partnered Drug Shows Significant Skin Clearance In Pivotal Psoriasis Study ↗
Protagonist and J&J report strong Phase 3 psoriasis data for icotrokinra and unveil potent next-gen IL-17 blocker PN-881 at SID meeting. 
Via Benzinga
News headline image
Johnson & Johnson’s Psoriasis Drug Meets Goal In Late Stage Study: Retail Yet To Be Impressed ↗
The company said that 66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational oral Icotrokinra achieved site-specific clear or almost clear skin at week 16. 
Via Stocktwits
News headline image
Mattel Appoints Kenvue CFO Paul Ruh As Finance Chief As Toy Maker Navigates Tariff Challenges ↗
Before Kenvue and Johnson & Johnson, Ruh was at PepsiCo for 17 years. 
Via Stocktwits
Topics Economy Government World Trade
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.